FIELD: medicine.
SUBSTANCE: invention aims at treatment, diagnostics or prevention of parasitic disease. There is used combination histone proteins H2A, H2B, H3 and H4 recovered from Leishmania infantum for making a pharmaceutical composition and a diagnostic aid. It involves applying a vector containing nucleotides coding specified histones.
EFFECT: invention allows treating and preventing the parasitic disease caused by one type with using histones originated from the other type.
13 cl, 4 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE CONTAINING RIBOSOMAL PROTEIN EXTRACT (RPE) AND Th1-ACTIVATING ADJUVANT | 2009 |
|
RU2521499C2 |
| METHOD FOR PURIFYING H4 HYSTONE RECEIVED FROM THYMUS TISSUE | 1985 |
|
SU1319352A1 |
| HISTONES AND BIODEGRADABLE LIPIDES AS MEANS FOR NUCLEIC ACIDS DELIVERY TO EUKARYOTIC CELLS | 2015 |
|
RU2637371C2 |
| DIAGNOSTICS OF PARASITIC DISEASE, SUCH AS LEISHMANIASIS, WITH APPLICATION OF RIBOSOMAL PROTEIN EXTRACT (RPE) | 2010 |
|
RU2558233C2 |
| NATURAL CATHIONE PROTEIN COMPLEX AND METHOD FOR PRODUCING IT | 1996 |
|
RU2176517C2 |
| METHOD FOR PREPARATIVE EXTRACTION OF BASIC PROTEINS FROM SUPERSTRUCTURES OF PLANT CELL NUCLEI | 2009 |
|
RU2408602C1 |
| EXPRESSION OF KSAC FUSION PROTEIN AND METHOD OF OBTAINING SOLUBLE PROTEINS BY HIGH PRESSURE | 2013 |
|
RU2647568C2 |
| EPIGENETIC REGULATORY COMPLEX OF GENE EXPRESSION CONTROL | 2007 |
|
RU2462512C2 |
| HISTONES AND/OR proADM AS MARKERS TESTIFYING ABOUT ORGAN DYSFUNCTION | 2017 |
|
RU2764766C2 |
| NUCLEIC ACID CONTAINING OR CODING HISTONE "STEM-LOOP" STRUCTURE AND SEQUENCE OF POLY (A) OR POLYADENYLATION SIGNAL, TO INCREASE EXPRESSION OF CODED PATHOGENIC ANTIGEN | 2013 |
|
RU2639528C2 |
